Who will pay for CRISPR? – STAT
STAT |
Who will pay for CRISPR?
STAT Spark Therapeutics of Philadelphia is vying to bring the first gene therapy to market in the U.S. to treat a rare genetic eye disease called Leber congenital amaurosis 2. Analysts said 5 it could cost a half-million dollars per eye. Like Glybera, Spark … |
